Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Acepodia Biotech, Inc.
SCG Cell Therapy Pte. Ltd.
Brooklyn ImmunoTherapeutics, LLC
Dana-Farber Cancer Institute
Fate Therapeutics
Fate Therapeutics
Corregene Biotechnology Co., Ltd
Mie University
Brooklyn ImmunoTherapeutics, LLC
Gruppo Oncologico del Nord-Ovest
Masonic Cancer Center, University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mie University
National Cancer Institute (NCI)
Herlev Hospital